• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Thoratec Corp

+ Add to Watchlist


19.970 EUR 0.033 0.17%

As of 03:05:30 ET on 09/16/2014.

Snapshot for Thoratec Corp (TL1)

Open: 19.965 Day's Range: 19.885 - 19.970 Volume: 0
Previous Close: 19.937 52wk Range: 16.844 - 31.865 1-Yr Rtn: -26.70%

Stock Chart for TL1

No chart data available.
  • TL1:GR 19.970
  • 1D
  • 1M
  • 1Y
Interactive TL1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TL1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.2632
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.3420
Est. PEG Ratio 2.2530
Market Cap (M EUR) 1,124.31
Shares Outstanding (M) 56.30
30 Day Average Volume 105
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TL1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TL1

Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.

Gerhard F Burbach "Gary"President/CEODavid A LehmanSenior VP/Secy/Gen Cnsl
Taylor C HarrisVP/CFOVasant PadmanabhanVP:Technical Operations
More Company Profile & Key Executives for TL1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil